Heart Disease Clinical Trials in Los Angeles

Showing 261-280 of 333 trials

Better Effectiveness After Transition - Heart Failure

NCT01360203

The purpose of this study is to compare the effect of implementing wireless remote monitoring combined with structured telephone monitoring, versus current care, on variation in rehospitalization among older patients hospitalized with heart failure at six medical centers.

Heart Failure

University of California, Los Angeles1,437 participantsStarted Oct 2011

Davis, California, United States • Irvine, California, United States • Los Angeles, California, United States +3 more locations

COMPLETEDPhase 3< 1 mile

Aldosterone Antagonist Therapy for Adults With Heart Failure and Preserved Systolic Function

NCT00094302

The purpose of this study is to evaluate the effectiveness of aldosterone antagonist therapy in reducing cardiovascular mortality, aborted cardiac arrest, and heart failure hospitalization in patients who have heart failure with preserved systolic function.

Cardiovascular DiseasesHeart DiseasesHeart Failure, Congestive

Carelon Research3,445 participantsStarted Aug 2006

Birmingham, Alabama, United States • Glendale, Arizona, United States • Phoenix, Arizona, United States +267 more locations

Better Effectiveness After Transition - Heart Failure

Aldosterone Antagonist Therapy for Adults With Heart Failure and Preserved Systolic Function

Heart Disease Trials in Other Cities

Endothelin Blockade in Patients With Single Ventricle Physiology

Iloprost for the Treatment of Pulmonary Hypertension in Adults With Congenital Heart Disease

A Pharmacodynamic Study With Ticagrelor in Hispanic Patients

Effectiveness and Safety of Ramipril Alone Compared With Telmisartan Alone and in Combination With Ramipril in Patients at High Risk for Cardiovascular Events. Patients Intolerant to Ramipril Were Entered in TRANSCEND, Telmisartan Compared to Placebo.

Clevidipine in the Treatment of Blood Pressure in Patients With Acute Heart Failure (PRONTO)

Niacin Plus Statin to Prevent Vascular Events

Does Prophylactic Coronary Artery Revascularization for High Risk Patients Reduce Long-term Risk of Mortality

Warfarin Versus Aspirin in Reduced Cardiac Ejection Fraction (WARCEF) Trial

Study To Evaluate D-Ribose For The Treatment of Congestive Heart Failure

Safety and Tolerability of Initiating LCZ696 in Heart Failure Patients

TAXUS Libertē Post Approval Study

Radial Artery Access With Ultrasound Trial

Effects of a High Protein Diet on Clinical Outcomes in Heart Failure

GORE Flow Reversal System and GORE Embolic Filter Extension Study

Monitoring Subjects With Fluid-Management Issues In the Home Environment

Type 2 Diabetes Evaluation of Ranolazine in Subjects With Chronic Stable Angina

Improving Clinician Communication Skills (ICCS)

Sensor Optimization of Cardiac Resynchronization Therapy Response

Other Conditions in Los Angeles